Handelsbanken Fonder AB Grows Holdings in Healthpeak Properties, Inc. $DOC

Handelsbanken Fonder AB boosted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 34.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 327,900 shares of the real estate investment trust’s stock after buying an additional 83,400 shares during the quarter. Handelsbanken Fonder AB’s holdings in Healthpeak Properties were worth $7,017,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of DOC. New York Life Investment Management LLC increased its position in shares of Healthpeak Properties by 65.8% in the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after purchasing an additional 61,952 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its position in shares of Healthpeak Properties by 176.0% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust’s stock worth $5,146,000 after purchasing an additional 204,100 shares during the last quarter. Swedbank AB grew its stake in Healthpeak Properties by 433.4% in the fourth quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust’s stock worth $13,655,000 after purchasing an additional 690,000 shares in the last quarter. Nan Fung Trinity HK Ltd. acquired a new position in Healthpeak Properties in the fourth quarter worth about $2,654,000. Finally, JPMorgan Chase & Co. increased its holdings in Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after buying an additional 2,438,278 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Down 0.1%

Healthpeak Properties stock opened at $20.78 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.95. The company has a 50-day simple moving average of $21.33 and a 200-day simple moving average of $18.90. The firm has a market capitalization of $14.33 billion, a P/E ratio of 59.38, a P/E/G ratio of 3.20 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. During the same period in the previous year, the business posted $0.46 EPS. Healthpeak Properties’s revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, equities analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is 348.57%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Scotiabank upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Mizuho boosted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, July 6th. Royal Bank Of Canada upped their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. BMO Capital Markets raised their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 15th. Finally, Evercore downgraded shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective for the company. in a report on Monday, May 11th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $21.44.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.